Bethesda-based Telcare Inc. has secured more than $25 million in equity funding.
Telcare, the developer of the first FDA-cleared wireless glucose monitoring system for people with diabetes, will use the funds for marketing, sales, research and development and ongoing operations.
Sequoia Capital led the round, which includes backing from existing investor, Qualcomm Inc., acting through itsQualcomm Life Fund.